Two China-US Life Science Investment Firms, Wuxi Ventures And Frontline, Will Merge
Published: May 23, 2017
Two prominent China-US healthcare investment firms plan to join forces: WuXi Healthcare Ventures and Frontline BioVentures will merge to form 6 Dimensions Capital. Together, the two firms have almost $800 million under management. 6 Dimensions plans to continue growing by starting two new funds, one dollar-based and the other renminbi. Dr. Ge Li, Chairman and CEO of WuXi AppTec, will serve as Chairman of 6 Dimensions, and Dr. Leon Chen, Managing Partner of Frontline, will be the firm's CEO. WuXi Ventures has focused on innovative US startups, while Frontline is an established China venture firm.